Recent

% | $
Quotes you view appear here for quick access.

Merrimack Pharmaceuticals, Inc. Message Board

  • michelle_michelle34 michelle_michelle34 Jul 19, 2013 12:26 PM Flag

    Note all the firms that do coverage research are part of the selling of stock and convertible bond: Mizhuo, Guggenheim Brean Capital, Cowen,

    Do you see how they all pumped the stock to get people to buy into the stock? Do you see Mizhuo Securities pumped the stock just on June 25th to BUY with a $12 price target and it rand from $5-7 in 2 weeks before the dump?

    Date Firm Type Rating (Past) PT
    (Past) Start $ End $ % Chg. Details
    6/25/2013 Mizuho Securities New Coverage Buy (N/A) 12.00 (N/A) 5.65 4.86 -13.98% Details
    11/9/2012 Guggenheim New Coverage Buy (N/A) 13.00 (N/A) 6.84 4.86 -28.95% Details
    9/27/2012 Brean Capital New Coverage Buy (N/A) 12.00 (N/A) 9.17 4.86 -47% Details
    5/8/2012 Cowen New Coverage Outperform (N/A) N/A (N/A) 7.50 4.86 -35.2% Details
    5/8/2012 Oppenheimer New Coverage Outperform (N/A) 12.00 (N/A) 7.50

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
MACK
6.24+0.26(+4.35%)Sep 26 4:00 PMEDT